Institutional Incidence of Severe tPA-Induced Angioedema in Ischemic Cerebral Vascular Accidents
Introduction. Tissue plasminogen activator (tPA) is commonly used in ischemic cerebral vascular accidents (CVAs). tPA is generally well tolerated; however, orolingual angioedema is a well-documented adverse effect. Angioedema is generally mild, transient, and unilateral but can manifest as severe, l...
Saved in:
Main Authors: | Matthew Sczepanski, Paul Bozyk |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Critical Care Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2018/9360918 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is Intravenous Heparin a Contraindication for TPA in Ischemic Stroke?
by: Zain Kulairi, et al.
Published: (2017-01-01) -
The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity
by: Daniel Torrente, et al.
Published: (2025-01-01) -
tPA-MMP-9 Axis Plays a Pivotal Role in Mobilization of Endothelial Progenitor Cells from Bone Marrow to Circulation and Ischemic Region for Angiogenesis
by: Steve Leu, et al.
Published: (2016-01-01) -
tPA‐GFP is a reliable probe for detecting compound exocytosis in human pancreatic β‐cells
by: Aishwarya A. Makam, et al.
Published: (2025-02-01) -
Less Experienced Telestroke Consultants Are More Likely to Go On-Camera, but Less Likely to Give tPA
by: Adam de Havenon, et al.
Published: (2019-01-01)